ACIP更新COVID-19疫苗分配临时建议(美国,2020年12月)
1b阶段为≥75岁人群和一线必要工作人员(非医护);1c阶段为65-74岁人群、16-64岁高危基础疾病患者及1b未覆盖的必要工作人员。建议为临时性,将随疫苗供应与疫情变化更新。
要点
- 1a阶段优先接种医护人员和长期护理机构居民。
- 1b阶段推荐≥75岁人群和一线必要工作人员(非医护)接种。
- 1c阶段推荐65-74岁、16-64岁高危基础疾病患者及剩余必要工作人员接种。
核心结论
- 在疫苗供应有限期间,ACIP建议按1a、1b、1c三个阶段分层分配COVID-19疫苗。
研究设计与样本
- ACIP基于COVID-19流行病学、伦理原则和接种项目实施考虑,制定临时分阶段分配建议。
关键数值与推荐
- 1a阶段:医护人员和长期护理机构居民优先接种。
- 1b阶段:≥75岁人群和一线必要工作人员(非医护)接种。
- 1c阶段:65-74岁人群、16-64岁高危基础疾病患者及1b未覆盖的必要工作人员接种。
临床怎么用
- 为联邦、州和地方辖区在疫苗供应有限时提供分阶段接种的分配依据。
- 接种实施中可按1a、1b、1c顺序安排人群接种。
局限性
- 该建议为临时性,可能根据FDA紧急使用授权条件、新疫苗授权、疫苗供应或流行病学变化更新。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The first vaccines for prevention of coronavirus disease 2019 (COVID-19) in the United States were authorized for emergency use by the Food and Drug Administration (FDA) (1) and recommended by the Advisory Committee on Immunization Practices (ACIP) in December 2020.* However, demand for COVID-19 vaccines is expected to exceed supply during the first months of the national COVID-19 vaccination program. ACIP advises CDC on population groups and circumstances for vaccine use.† On December 1, ACIP recommended that 1) health care personnel§ and 2) residents of long-term care facilities¶ be offered COVID-19 vaccination first, in Phase 1a of the vaccination program (2). On December 20, 2020, ACIP recommended that in Phase 1b, vaccine should be offered to persons aged ≥75 years and frontline essential workers (non-health care workers), and that in Phase 1c, persons aged 65-74 years, persons aged 16-64 years with high-risk medical conditions, and essential workers not recommended for vaccination in Phase 1b should be offered vaccine.** These recommendations for phased allocation provide guidance for federal, state, and local jurisdictions while vaccine supply is limited. In its deliberations, ACIP considered scientific evidence regarding COVID-19 epidemiology, ethical principles, and vaccination program implementation considerations. ACIP's recommendations for COVID-19 vaccine allocation are interim and might be updated based on changes in conditions of FDA Emergency Use Authorization, FDA authorization for new COVID-19 vaccines, changes in vaccine supply, or changes in COVID-19 epidemiology.
引用
- Dooling K, Marin M, Wallace M, et al. The Advisory Committee on Immunization Practices' Updated Interim Recommendation for Allocation of COVID-19 Vaccine - United States, December 2020. MMWR Morb Mortal Wkly Rep. 2021. PMID: 33382671. doi:10.15585/mmwr.mm695152e2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。